Evidence 1
Activity
Activity
Blood-Brain Barrier
3.31-fold higher than saline
Target
bEnd.3 and c6 cells
Assay & Model
Confocal microscopy
It crosses the BBB.
Origin/Source
PTX-1.7 mg/kg, CD-3.6 mg/kg
Glioma
Stability/half life
Source & Reference
NA
B3Pdb
Other
Chemically synthesized
Intravenous
D-T7 Peptide Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Ant
Combined with Cediranib and Paclitaxel.